Marius Pearson
Oxford PharmaGenesis is helping to raise public awareness of the importance of patient diversity in clinical trials through a campaign partnership with the non-profit organization Center for Information and Study on Clinical Research Participation (CISCRP).
Oxford PharmaGenesis continues to boost colleagues’ skills and expertise through a wide range of professional and personal development sessions offered to celebrate Learning at Work Week 2021 (17–23 May).
Monday 10 May to Wednesday 12 May A focus of the 2021 Clinical Data Disclosure, Transparency and Plain Language Summaries virtual conference was on the forthcoming implementation of the EU Clinical Trial Regulation (EU CTR) and the launch of the Clinical Trial Information Service (CTIS). However, the important role of different forms of plain language […]
Oxford PharmaGenesis is delighted to have supported the publication of a Delphi consensus manuscript in the Journal of the American Society of Nephrology. The publication highlights the need to increase awareness among key stakeholders of racial health disparities in kidney disease and of APOL1-associated nephropathy.
Oxford PharmaGenesis has made its first appointments to the new role of Director of Innovation, created specifically to support teams across the global organization in utilizing new and emerging technology to support their clients’ unmet needs.
Oxford PharmaGenesis has been designated a centre of Excellence in Wellbeing this year by Great Place to Work®. The accolade recognizes organizations with excellent well-being practices and is a welcome acknowledgement of our increasing efforts to foster a culture of openness, empowerment and support in the workplace.
Richard White, COO of Oxford PharmaGenesis, was a panellist at the recent virtual workshop on ‘Artificial intelligence (AI) to accelerate discovery’, hosted by the Friends of the National Library of Medicine (FNLM) and sponsored by Oxford PharmaGenesis. He discussed emerging trends in the use of AI by the pharmaceutical industry, with a focus on how […]
Oxford PharmaGenesis has been recognized across offices worldwide with an internationally renowned UK Best WorkplacesTM award. The accreditation is thanks to colleagues who rated the leading independent HealthScience communications consultancy as ‘a great place to work’ in the Great Place to Work® 2021 survey.
Together with Pfizer Inc. and Digital Science, Oxford PharmaGenesis colleagues have co-developed an AI-based literature interrogation tool that will help researchers to identify biomarkers of emerging scientific interest in oncology.
Share this page Overview Day 1 report Day 2 report Day 3 report Day 3 key take-homes and insights Patient engagement in a post-COVID world Speakers: Alex Morton (NucleusX Consulting); Gerard Mortimer (Synaptik Digital) The global COVID-19 pandemic has increased our dependence on digital platforms for work, school, socializing and even for accessing healthcare. The […]
